Study evaluates GLP-1 RA versus SGLT2 inhibitor use and all-cause mortality and major adverse cardiovascular events in adults with and without serious mental illness.
The clinical trial, published in JAMA Psychiatry Wednesday, found the treatment reduced depressive symptoms for more than 35% of participants, who received two 40-minute ketamine infusions over two weeks.
Dr. Yasmin Hummadi explores how integrating spiritual well-being and emotional regulation can calm the nervous system and alleviate inflammatory skin conditions.
As baby boomers retire en masse, healthcare employers are using 'temp-to-direct' strategies and targeted college partnerships to train and retain essential administrative staff.
Young people today do not know more about sexual health than their peers did 10 or 20 years ago, said Rachel Bergen, who led the report as sexual health evaluation project lead at UBC.